Neogen Corporation delivered third-quarter results ahead of market expectations, supported by resilient growth in its food safety division and disciplined cost management. While overall revenue declined year-on-year, margin expansion and upgraded full-year guidance signal improving operational efficiency. The results highlight a divergence between segment performance and underscore ongoing execution risks in the animal safety business.

Key Highlights:

  • Neogen (NASDAQ: NEOG) reported adjusted EPS of USD 0.09, exceeding consensus estimates by USD 0.03
  • Revenue of USD 211.2 million beat expectations but declined 4.4% year-on-year
  • Food Safety segment delivered 4.0% core growth, led by Europe and Latin America
  • Adjusted EBITDA margin expanded to 22.8%, up 110 basis points sequentially
  • Full-year revenue guidance raised to USD 857–860 million, above prior outlook

Earnings Beat Driven by Operational Discipline and Segment Mix

Neogen Corporation (NASDAQ: NEOG) reported third-quarter fiscal 2026 earnings that surpassed analyst expectations, reflecting a combination of cost discipline and strength in its higher-margin food safety business. Adjusted earnings per share came in at USD 0.09, ahead of the USD 0.06 consensus estimate, while revenue of USD 211.2 million also exceeded forecasts.

Despite the headline beat, total revenue declined 4.4% compared with USD 221.0 million in the same period last year. The results indicate that operational improvements and margin expansion, rather than topline growth, were the primary drivers of earnings performance during the quarter.

The company’s shares rose modestly in pre-market trading following the announcement, suggesting a measured market response to the mixed underlying trends.

Food Safety Segment Continues to Anchor Growth

Neogen’s Food Safety segment remained the central driver of performance, delivering 4.0% core revenue growth during the quarter. This builds on momentum observed in the prior quarter and reflects sustained demand across key international markets.

Regional expansion was led by Latin America and Europe, where regulatory standards and food supply chain monitoring continue to support demand for diagnostic and testing solutions. The segment’s performance underscores the structural resilience of food safety markets, which tend to exhibit relatively stable demand irrespective of broader economic cycles.

This segment also plays a critical role in Neogen’s margin profile, given its relatively higher profitability compared with other business lines.

Animal Safety Weakness Highlights Supply Chain Constraints

In contrast, the Animal Safety segment reported an 8.7% decline in core revenue, reflecting ongoing challenges linked to third-party supplier disruptions. The weakness highlights continued execution risks within this segment, particularly as the company navigates supply chain dependencies.

The divergence between the two segments underscores an uneven recovery profile across Neogen’s portfolio. While food safety benefits from structural tailwinds, animal safety appears more exposed to operational disruptions and external dependencies.

This imbalance remains a key factor influencing the company’s consolidated growth trajectory.

Margin Expansion Supported by Cost Rationalisation Measures

A notable feature of the quarter was the expansion in profitability despite lower year-on-year revenue. Adjusted EBITDA rose to USD 48.2 million, with margins improving to 22.8%, representing a 110 basis point increase sequentially.

The improvement was largely driven by cost control initiatives, including a workforce reduction programme initiated in the first quarter. Adjusted operating expenses declined 9% sequentially, indicating early benefits from restructuring efforts.

Adjusted net income for the quarter stood at USD 19.4 million, reflecting the combined effect of margin expansion and disciplined expense management.

The results suggest that Neogen is increasingly focused on operational efficiency as a lever to offset revenue variability and support earnings stability.

Upgraded Revenue Guidance Signals Improved Visibility

Neogen raised its full-year fiscal 2026 revenue guidance to a range of USD 857 million to USD 860 million, with the midpoint exceeding market expectations. This compares with its previous guidance range of USD 845 million to USD 855 million.

The revised outlook indicates improved confidence in near-term demand, particularly within the Food Safety segment. However, the company maintained its adjusted EBITDA guidance of approximately USD 175 million, suggesting a balanced approach to growth and profitability expectations.

Neogen also indicated that it expects to achieve positive free cash flow for the full year, pointing to improving cash generation dynamics.

Strategic Initiatives and Long-Term Execution Outlook

The company’s ongoing Petrifilm manufacturing transition remains on track for completion by November 2027. Initial product validation results have been described as promising, suggesting potential long-term benefits in production efficiency and product consistency.

This transition represents a significant operational initiative and is likely to influence Neogen’s cost structure and scalability over the medium term.

However, execution risks remain, particularly in managing supply chain dependencies within the Animal Safety segment and maintaining consistent growth across geographies.

Market Positioning Reflects Mixed but Improving Fundamentals

Neogen’s third-quarter results highlight a company in transition, balancing structural growth opportunities in food safety with operational challenges in other segments. The combination of earnings outperformance, margin expansion, and upgraded revenue guidance points to improving internal execution.

At the same time, the year-on-year revenue decline and segment divergence suggest that growth remains uneven. The company’s ability to sustain momentum in its core food safety business while stabilising animal safety operations will be central to its financial trajectory in the coming quarters.